HOME >> BIOLOGY >> NEWS
Poultry consumption, handling are risk factors for antibiotic resistance in humans

Marshfield, Wis. -- Antibiotic use as a livestock growth promoter increases the risk of human antibiotic resistance, a Marshfield Clinic researcher and his colleagues have found.

Results of the nearly $1.4 million three-year study, funded by the Centers for Disease Control and Prevention, Atlanta, Georgia, are in the November 1 issue of The Journal of Infectious Diseases.

Edward Belongia, M.D., Marshfield Clinic Research Foundation, Marshfield, Wis., and his colleagues examined poultry exposure as a risk factor for antibiotic resistance in Enterococcus faecium, a gut bacterium that is increasingly the cause of infections in hospitals. The investigation team focused on use of a growth-promoting antibiotic, called virginiamycin, in poultry.

Virginiamycin is closely related to quinupristin-dalfopristin, an antibiotic licensed to treat patients with serious, antibiotic-resistant infections. The drug is prescribed under the brand name Synercid. According to Belongia, "There is a relative lack of data on the impact of antibiotic use in livestock and its relationship to antibiotic resistance in humans, but there is a fair amount of indirect evidence suggesting that antibiotic use could pose a risk to human health."

"We've known for a long time that resistant bacteria can be found on retail poultry products, but our study is one of the first to show an association between human carriage of antibiotic resistance genes and eating poultry or handling raw poultry.

"These results indicate that virginiamycin use in poultry leads to transfer of antibiotic resistance genes to human gut bacteria through the food supply and they provide additional evidence that use of growth promoters in animals may have long-term consequences for human health. The Food and Drug Administration (FDA) can use this information to improve its risk assessment procedures."

The importance of this issue was illustrated by a recent FDA Veterinary Medicine Advisory Commi
'"/>

Contact: Chris Schellpfeffer
cschell@lsb.com
608-268-5318
Marshfield Clinic
10-Oct-2006


Page: 1 2 3

Related biology news :

1. Squid-inspired design could mean better handling of underwater vehicles
2. Research aims for more efficiency in harvest and handling
3. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
4. Genetic factors strongly shape how peers are chosen
5. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
6. Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model
7. Growth factors and environment combine to increase brain maturation
8. First confirmed common genetic risk factors for breast cancer
9. UC engineering researchers uncover factors that control ion motion in solid electrolytes
10. A cherry on top: Tart cherries may alter heart/diabetes factors
11. Cherries may help reduce metabolic syndrome and heart disease risk factors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... (PRWEB) , ... August 05, 2020 , ... Regenative Labs ... two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to ... using a syringe. The company’s solutions are the first Wharton’s jelly allograft product to ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead upcoming ... term focus on Type 2 diabetes and associated comorbidities. , Justin brings over ... and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/18/2020)... ... 2020 , ... Commercial launch readiness is a critical stage in a product ... or vaccine, the global economic downturn will only increase price pressures overall for the ... capturing full value from every product launch is critical. However, history shows that only ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... 11, 2020 , ... The FSHD Society announced today that ... Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on funding of ... academic research centers in the United States and Europe with expertise in FSHD ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its ... MediVet Biologics since its formation in 2016, the company is relaunching itself under the ... on its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... that they have entered into a strategic partnership whereby Catalent will provide support ...
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance ... a successful study, while protecting and accessing the catheter or device post-surgery is often ... Envigo in a live webinar on Wednesday, August 5, 2020 ...
Breaking Biology Technology:
Cached News: